Abstract
The purpose of the present study was to investigate the prevalence and incidence of gout in Korea and predict the future prevalence and incidence of gout. Data were collected from the national health claims database. Patients who had at least one claim for gout between 2007 and 2015 were included in the study. The prevalence of gout from 2007 to 2015 and the incidence of gout from 2009 to 2015 were determined. We estimated sex- and age-specific prevalence and incidence of gout during the period. The prevalence and incidence of gout were predicted using time series analysis. The prevalence of gout (95% CI) increased from 3.49 (3.48–3.51) per 1000 persons in 2007 to 7.58 (7.55–7.60) per 1000 persons in 2015. The incidence of gout (95% CI) was 1.52 (1.51–1.53) in 2009 and rose to 1.94 (1.93–1.95) per 1000 persons in 2015. The prevalence and incidence of gout were higher in men than in women. The older population had a higher prevalence and incidence than the younger population. The increase in prevalence was higher in the older population than the younger population, whereas the increase in incidence was higher in the younger population than the older population. The predicted prevalence and incidence of gout (95% CI) in 2025 were 16.59 (15.85–17.34) per 1000 persons and 3.81 (3.14–4.47) per 1000 persons. The prevalence and incidence of gout increased in Korea between 2007 and 2015. Men and the older population had a higher prevalence and incidence of gout compared to women and the younger population. However, the incidence of gout in the younger population has increased rapidly in recent years.
Similar content being viewed by others
References
Riedel AA, Nelson M, Wallace K, Joseph-Ridge N, Cleary M, Fam AG (2004) Prevalence of comorbid conditions and prescription medication use among patients with gout and hyperuricemia in a managed care setting. J Clin Rheumatol 10(6):308–314. doi:10.1097/01.rhu.0000147049.12220.32
Rho YH, Choi SJ, Lee YH, Ji JD, Choi KM, Baik SH, Chung SH, Kim CG, Choe JY, Lee SW, Chung WT, Song GG (2005) The prevalence of metabolic syndrome in patients with gout: a multicenter study. J Korean Med Sci 20(6):1029–1033. doi:10.3346/jkms.2005.20.6.1029
Janssens HJ, Arts PG, Schalk BW, Biermans MC (2016) Gout and rheumatoid arthritis, both to keep in mind in cardiovascular risk management: a primary care retrospective cohort study. Joint Bone Spine. doi:10.1016/j.jbspin.2015.12.003
Chou CT, Lai JS (1998) The epidemiology of hyperuricaemia and gout in Taiwan aborigines. Br J Rheumatol 37(3):258–262
Tu FY, Lin GT, Lee SS, Tung YC, Tu HP, Chiang HC (2015) Prevalence of gout with comorbidity aggregations in southern Taiwan. Joint Bone Spine 82(1):45–51. doi:10.1016/j.jbspin.2014.07.002
Klemp P, Stansfield SA, Castle B, Robertson MC (1997) Gout is on the increase in New Zealand. Ann Rheum Dis 56(1):22–26
Zhu Y, Pandya BJ, Choi HK (2011) Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007–2008. Arthritis Rheum 63(10):3136–3141. doi:10.1002/art.30520
Kuo CF, Grainge MJ, Mallen C, Zhang W, Doherty M (2015) Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann Rheum Dis 74(4):661–667. doi:10.1136/annrheumdis-2013-204463
Nan H, Qiao Q, Dong Y, Gao W, Tang B, Qian R, Tuomilehto J (2006) The prevalence of hyperuricemia in a population of the coastal city of Qingdao, China. J Rheumatol 33(7):1346–1350
Miao Z, Li C, Chen Y, Zhao S, Wang Y, Wang Z, Chen X, Xu F, Wang F, Sun R, Hu J, Song W, Yan S, Wang CY (2008) Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China. J Rheumatol 35(9):1859–1864
Arromdee E, Michet CJ, Crowson CS, O’Fallon WM, Gabriel SE (2002) Epidemiology of gout: is the incidence rising? J Rheumatol 29(11):2403–2406
Kuo CF, Grainge MJ, See LC, Yu KH, Luo SF, Zhang W, Doherty M (2015) Epidemiology and management of gout in Taiwan: a nationwide population study. Arthritis Res Ther 17:13. doi:10.1186/s13075-015-0522-8
Kim EH, Jeon K, Park KW, Kim HJ, Ahn JK, Jeon CH, Cha H-S, Koh E-M (2004) The prevalence of gout among hyperuricemic population (the prevalence of gout among hyperuricemic population). J Rheum Dis 11(1):7–13
Lee CH, Sung NY (2011) The prevalence and features of Korean gout patients using the National Health Insurance Corporation database. J Rheum Dis 18(2):94–100
Koo BK, Lee CH, Yang BR, Hwang SS, Choi NK (2014) The incidence and prevalence of diabetes mellitus and related atherosclerotic complications in Korea: a National Health Insurance Database Study. PLoS One 9(10):e110650. doi:10.1371/journal.pone.0110650
Shim JS, Sung YK, Joo YB, Lee HS, Bae SC (2014) Prevalence and incidence of systemic lupus erythematosus in South Korea. Rheumatol Int 34(7):909–917. doi:10.1007/s00296-013-2915-9
Park SJ, Kwon KE, Choi NK, Park KH, Woo SJ (2015) Prevalence and incidence of exudative age-related macular degeneration in South Korea: a nationwide population-based study. Ophthalmology 122(10):2063–2070.e2061. doi:10.1016/j.ophtha.2015.06.018
Trifiro G, Morabito P, Cavagna L, Ferrajolo C, Pecchioli S, Simonetti M, Bianchini E, Medea G, Cricelli C, Caputi AP, Mazzaglia G (2013) Epidemiology of gout and hyperuricaemia in Italy during the years 2005–2009: a nationwide population-based study. Ann Rheum Dis 72(5):694–700. doi:10.1136/annrheumdis-2011-201254
Bardin T, Bouée S, Clerson P, Chalès G, Flipo RM, Lioté F, Perez V, Poiraud T, Schaeverbeke T, Richette P (2016) Prevalence of gout in the adult population of France. Arthritis Care Res 68(2):261–266
Teng GG, Ang LW, Saag KG, Yu MC, Yuan JM, Koh WP (2012) Mortality due to coronary heart disease and kidney disease among middle-aged and elderly men and women with gout in the Singapore Chinese Health Study. Ann Rheum Dis 71(6):924–928. doi:10.1136/ard.2011.200523
Kuo CF, Grainge MJ, See LC, Yu KH, Luo SF, Valdes AM, Zhang W, Doherty M (2015) Familial aggregation of gout and relative genetic and environmental contributions: a nationwide population study in Taiwan. Ann Rheum Dis 74(2):369–374. doi:10.1136/annrheumdis-2013-204067
Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G (2004) Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 350(11):1093–1103. doi:10.1056/NEJMoa035700
Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G (2004) Alcohol intake and risk of incident gout in men: a prospective study. Lancet 363(9417):1277–1281. doi:10.1016/s0140-6736(04)16000-5
Choi HK, Curhan G (2008) Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. BMJ 336(7639):309–312. doi:10.1136/bmj.39449.819271.BE
Choi HK, Atkinson K, Karlson EW, Curhan G (2005) Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med 165(7):742–748. doi:10.1001/archinte.165.7.742
Bhole V, de Vera M, Rahman MM, Krishnan E, Choi H (2010) Epidemiology of gout in women: fifty-two-year followup of a prospective cohort. Arthritis Rheum 62(4):1069–1076. doi:10.1002/art.27338
Saag KG, Choi H (2006) Epidemiology, risk factors, and lifestyle modifications for gout. Arthritis Res Ther 8(Suppl 1):S2. doi:10.1186/ar1907
Adamopoulos D, Vlassopoulos C, Seitanides B, Contoyiannis P, Vassilopoulos P (1977) The relationship of sex steroids to uric acid levels in plasma and urine. Acta Endocrinol (Copenh) 85(1):198–208
Hak AE, Curhan GC, Grodstein F, Choi HK (2010) Menopause, postmenopausal hormone use and risk of incident gout. Ann Rheum Dis 69(7):1305–1309. doi:10.1136/ard.2009.109884
Roubenoff R, Klag MJ, Mead LA, Liang KY, Seidler AJ, Hochberg MC (1991) Incidence and risk factors for gout in white men. JAMA 266(21):3004–3007
Maynard JW, McAdams-DeMarco MA, Law A, Kao L, Gelber AC, Coresh J, Baer AN (2014) Racial differences in gout incidence in a population-based cohort: atherosclerosis Risk in Communities Study. Am J Epidemiol 179(5):576–583. doi:10.1093/aje/kwt299
Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Schumacher HR Jr, Saag KG (2005) Gout epidemiology: results from the UK General Practice Research Database, 1990-1999. Ann Rheum Dis 64(2):267–272. doi:10.1136/ard.2004.024091
Elliot AJ, Cross KW, Fleming DM (2009) Seasonality and trends in the incidence and prevalence of gout in England and Wales 1994-2007. Ann Rheum Dis 68(11):1728–1733. doi:10.1136/ard.2008.096693
Cea Soriano L, Rothenbacher D, Choi HK, Garcia Rodriguez LA (2011) Contemporary epidemiology of gout in the UK general population. Arthritis Res Ther 13(2):R39. doi:10.1186/ar3272
Dehlin M, Drivelegka P, Sigurdardottir V, Svard A, Jacobsson LT (2016) Incidence and prevalence of gout in Western Sweden. Arthritis Res Ther 18:164. doi:10.1186/s13075-016-1062-6
Acknowledgements
This work was supported by a grant of the Research Institute of Medical Science, Catholic University of Daegu (2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Ji-Won Kim, Sang Gyu Kwak, Hwajeong Lee, Seong-Kyu Kim, Jung-Yoon Choe, and Sung-Hoon Park declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.
Human and animal rights
This article does not contain any studies with animals performed by any of the authors.
Funding
No external funding was obtained for performing this study.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Kim, JW., Kwak, S.G., Lee, H. et al. Prevalence and incidence of gout in Korea: data from the national health claims database 2007–2015. Rheumatol Int 37, 1499–1506 (2017). https://doi.org/10.1007/s00296-017-3768-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-017-3768-4